Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$13.58 - $17.36 $159,429 - $203,806
11,740 New
11,740 $184,000
Q4 2022

Feb 14, 2023

SELL
$14.85 - $19.04 $846,197 - $1.08 Million
-56,983 Reduced 97.61%
1,393 $22,000
Q3 2022

Nov 14, 2022

BUY
$12.38 - $20.23 $722,694 - $1.18 Million
58,376 New
58,376 $1.08 Million
Q2 2018

Aug 14, 2018

SELL
$20.06 - $44.95 $200,600 - $449,500
-10,000 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$20.04 - $29.71 $200,400 - $297,100
10,000 New
10,000 $200,000

Others Institutions Holding DCPH

About Deciphera Pharmaceuticals, Inc.


  • Ticker DCPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 66,822,100
  • Description
  • Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...
More about DCPH
Track This Portfolio

Track Balyasny Asset Management LLC Portfolio

Follow Balyasny Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Balyasny Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Balyasny Asset Management LLC with notifications on news.